Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hendriks

Showing results (231-240 of 344) with videos related to

Pageof 35
Sort By:
Respiratory Medicine and Research|September 27, 2020
Immune checkpoint inhibitors versus second line chemotherapy for patients with lung cancer refractory to first line chemotherapyC Lefebvre, E Martin, L E L Hendriks, et al.
FEBS Letters|March 9, 1999
Identification of caspases that cleave presenilin-1 and presenilin-2. Five presenilin-1 (PS1) mutations do not alter the sensitivity of PS1 to caspasesM van de Craen, C de Jonghe, I van den Brande, et al.
JACC. Clinical Electrophysiology|February 8, 2023
An Exercise and Physical Activity Program in Patients With Atrial Fibrillation: The ACTIVE-AF Randomized Controlled TrialAdrian D Elliott, Christian V Verdicchio, Rajiv Mahajan, et al.
Current Developments in Nutrition|May 14, 2023
Beyond the Food Systems Summit: Linking Recommendations to Action-The True Cost of FoodEileen T Kennedy, Maximo A Torero, Dariush Mozaffarian, et al.
Frontiers in Oncology|January 24, 2022
Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune TherapyEvelien A J van Genugten, Jetty A M Weijers, Sandra Heskamp, et al.
Pharmacoepidemiology and Drug Safety|June 13, 2023
Comparison of characteristics of patients with lung cancer in U.K. primary care databases: Clinical Practice Research Datalink Aurum and GOLDJ L Gulikers, A J van Veelen, J H M Driessen, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2026
Efficacy of alectinib for ALK-positive NSCLC according to tumor burden and body mass index: A pooled analysis of the randomized phase III trials ALEX and J-ALEXMarco Tagliamento, Marco Bruzzone, Eva Blondeaux, et al.
JTO Clinical and Research Reports|December 30, 2024
Prognostic and Predictive Biomarkers of Oligometastatic NSCLC: New Insights and Clinical ApplicationsMandy Jongbloed, Martina Bortolot, Leonard Wee, et al.
Cancers|December 24, 2021
Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory StudyRianne D W Vaes, Kobe Reynders, Jenny Sprooten, et al.
Human Reproduction (Oxford, England)|October 1, 2014
Short-term changes in hormonal profiles after laparoscopic ovarian laser evaporation compared with diagnostic laparoscopy for PCOSM L Hendriks, T König, T Korsen, et al.
Pageof 35

Showing results (231-240 of 344) with videos related to

Sort By:
Pageof 35
Respiratory Medicine and Research|September 27, 2020
Immune checkpoint inhibitors versus second line chemotherapy for patients with lung cancer refractory to first line chemotherapyC Lefebvre, E Martin, L E L Hendriks, et al.
FEBS Letters|March 9, 1999
Identification of caspases that cleave presenilin-1 and presenilin-2. Five presenilin-1 (PS1) mutations do not alter the sensitivity of PS1 to caspasesM van de Craen, C de Jonghe, I van den Brande, et al.
JACC. Clinical Electrophysiology|February 8, 2023
An Exercise and Physical Activity Program in Patients With Atrial Fibrillation: The ACTIVE-AF Randomized Controlled TrialAdrian D Elliott, Christian V Verdicchio, Rajiv Mahajan, et al.
Current Developments in Nutrition|May 14, 2023
Beyond the Food Systems Summit: Linking Recommendations to Action-The True Cost of FoodEileen T Kennedy, Maximo A Torero, Dariush Mozaffarian, et al.
Frontiers in Oncology|January 24, 2022
Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune TherapyEvelien A J van Genugten, Jetty A M Weijers, Sandra Heskamp, et al.
Pharmacoepidemiology and Drug Safety|June 13, 2023
Comparison of characteristics of patients with lung cancer in U.K. primary care databases: Clinical Practice Research Datalink Aurum and GOLDJ L Gulikers, A J van Veelen, J H M Driessen, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2026
Efficacy of alectinib for ALK-positive NSCLC according to tumor burden and body mass index: A pooled analysis of the randomized phase III trials ALEX and J-ALEXMarco Tagliamento, Marco Bruzzone, Eva Blondeaux, et al.
JTO Clinical and Research Reports|December 30, 2024
Prognostic and Predictive Biomarkers of Oligometastatic NSCLC: New Insights and Clinical ApplicationsMandy Jongbloed, Martina Bortolot, Leonard Wee, et al.
Cancers|December 24, 2021
Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory StudyRianne D W Vaes, Kobe Reynders, Jenny Sprooten, et al.
Human Reproduction (Oxford, England)|October 1, 2014
Short-term changes in hormonal profiles after laparoscopic ovarian laser evaporation compared with diagnostic laparoscopy for PCOSM L Hendriks, T König, T Korsen, et al.
Pageof 35